Effects of prostaglandin E1 metabolites on the induction of arterial thromboresistance.
Sinzinger H, Neumann I, O'Grady J, Rogatti W, Peskar BA.
Prostaglandins Other Lipid Mediat · journal article · DOI 10.1016/s0090-6980(98)00025-2 PUBLIKATIONSREGISTRET
Gå till forskningen.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för 13,14-dihydro-15-oxoprostaglandin E1. Visa hela publikationsregistret
En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publikationer i urvalet
14 träffarPurification, cDNA cloning and expression of 15-oxoprostaglandin 13-reductase from pig lung.
Ensor CM, Zhang H, Tai HH.
Biochem J · research support, u.s. gov't, p.h.s.; research support, non-u.s. gov't; research-article; journal article · DOI 10.1042/bj3300103In vivo formation of prostaglandin E1 and prostaglandin E2 in atopic dermatitis.
Leonhardt A, Krauss M, Gieler U, Schweer H, Happle R, Seyberth HW.
Br J Dermatol · journal article · DOI 10.1111/j.1365-2133.1997.tb14939.xInterindividual variation in the enzymatic 15-keto-reduction of 13,14-dihydro-15-keto-prostaglandin E1 in human liver and in human erythrocytes.
Rady-Pentek P, Mueller R, Tang BK, Kalow W.
Eur J Clin Pharmacol · journal article · DOI 10.1007/s002280050264FTIR spectral study of intramolecular hydrogen bonding in E-type of 15-keto-prostaglandins in dilute CCl4 solution: structure-activity relationships.
Takasuka M, Yamakawa M.
Bioorg Med Chem · journal article · DOI 10.1016/0968-0896(95)00037-hComparison of the inhibitory effect of E-prostaglandins in human and rabbit platelet-rich plasma and washed platelets.
Kobzar G, Mardla V, Järving I, Lõhmus M, Vahemets A, Samel N, Lille U.
Comp Biochem Physiol C Comp Pharmacol Toxicol · comparative study; journal article · DOI 10.1016/0742-8413(93)90168-kEffect of prostaglandin (PG) E1 and its initial metabolites on neutrophil-induced inhibition of human platelet aggregation.
Pallapies D, Peskar BA.
Thromb Res · comparative study; journal article · DOI 10.1016/0049-3848(93)90096-7Synergism between PGE1-metabolites(13,14-dihydro-prostaglandin E1, 15-keto prostaglandin E1, 15-keto-13,14-dihydro-prostaglandin E1) and nitric oxide (NO) on platelet aggregation.
Katzenschlager R, Weiss K, Rogatti W, Peskar BA, Sinzinger H.
Prostaglandins Leukot Essent Fatty Acids · journal article · DOI 10.1016/0952-3278(92)90114-xOn the metabolism of prostaglandin E1 administered intravenously to human volunteers.
Peskar BA, Cawello W, Rogatti W, Rudofsky G.
J Physiol Pharmacol · research support, non-u.s. gov't; journal articleFormation of 13,14-dihydro-prostaglandin E1 during intravenous infusions of prostaglandin E1 in patients with peripheral arterial occlusive disease.
Peskar BA, Hesse WH, Rogatti W, Diehm C, Rudofsky G, Schweer H, Seyberth HW.
Prostaglandins · research support, non-u.s. gov't; journal article · DOI 10.1016/0090-6980(91)90042-e[Metabolism of intravenously administered prostaglandin E1 in patients with peripheral arterial occlusive disease].
Hesse WH, Rudofsky G, Peskar BA.
Wien Klin Wochenschr · journal article; english abstractOmega-hydroxylation of prostaglandin E1 in the isolated perfused lungs of pregnant rabbits.
Leithauser MT, Roerig DL, Winquist SM, Gee A, Okita RT, Masters BS.
Prostaglandins · research support, u.s. gov't, p.h.s.; journal article · DOI 10.1016/0090-6980(88)90059-7In vivo disposition of prostaglandin E1 via pharmacokinetic characterization of its pulmonary metabolite.
Verburg M, Bothwell W, Daniels EG, Fitzpatrick FA.
J Cardiovasc Pharmacol · journal article · DOI 10.1097/00005344-198211000-00016Further identification of PGE1 metabolites formed in the cat lung.
Cozzini BO, Dawson CA.
Can J Physiol Pharmacol · research support, u.s. gov't, p.h.s.; research support, u.s. gov't, non-p.h.s.; journal article · DOI 10.1139/y77-045